Rhythm Biosciences Ltd has officially launched its enhanced geneType TM Colorectal Cancer (CRC) Risk Assessment clinical test, a notable development aimed at improving the...
URGENT UPDATE: Global leaders in biotechnology are set to converge in San Francisco on January 14, 2026, for the highly anticipated 5th Annual Biotech...